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Abstract 
This research is aimed to develop a 10-year risk prediction model and identify key contributing 
Cardiovascular Disease (CVD) risk factors. A Cox proportional hazard regression method was 
adopted to design and develop the risk model. We used Framingham Original Cohort dataset of 5079 
men and women aged 30 - 62 years, who had no overt symptoms of CVD at the baseline. Out of 
them, 3189 (62.78%) had an actual CVD event. A 10-year CVD risk model based on multiple risk 
factors (such as age, sex, body mass index (BMI), hypertension, systolic blood pressure, cigarettes 
per day, pulse rate, and diabetes) was developed in which heart rate was identified as one of the 
novel contributing risk factors. We validated the model via statistical and empirical validation 
methods. The proposed model achieved an acceptable discrimination and calibration with C-index 
(receiver operating characteristic (ROC)) being 0.71 from the validation dataset. 
 
Keywords: Cardiovascular Disease, Cox model, Predictive model, CVD risk, Early detection 
of CVD, Framingham risk score 
 
1. Introduction 
Many cardiovascular-related morbidities and mortalities are preventable by effective health 
management and employing effective diet plans, lifestyle interventions, and drug administration. For 
example, by assessing cardiovascular disease (CVD) risk factors regularly and introducing lifestyle 
adjustments or clinical treatments, the CVD can be prevented (Bansilal, Castellano, & Fuster, 2015). 
The CVD occurs due to variety of conditions and ultimately affect the heart and blood circulation 
system. Due to the high rate of disease morbidity, CVD has become a leading cause of mortality 
around the world. In New Zealand, statistics on CVD mortality in 2017 suggests that the percentage 
of deaths caused by CVD is 33% for the New Zealanders (Bannink, Wells, Broad, Riddell, & 
Jackson, 2006). However, challenges and issues regarding the development of CVD risk assessment 
models still exist (Crowson et al., 2017; Panaite, Salomon, Jin, & Rottenberg, 2015). CVD risk 
models based on single risk factor cannot realize the influence of multiple factors simultaneously. 
Risk assessment models using statistical regression methods prefer to use classic risk factors such as 
age, smoking, diabetes, sex, high blood pressure and total cholesterol to estimate the risk score 
(D’agostino et al., 2008). Studies applying data mining or machine learning techniques for the CVD 
risk estimations cannot provide an absolute risk assessment for the next certain years, although some 
of these models tried to incorporate novel predictors in the risk models. This research aims to identify 
novel risk factors for CVD by employing conventional predictors and then enhancing the risk 
estimation by developing a multi-variable-based risk prediction model that targets 5-year and 10-
year CVD events (Zhao, Liu, Xie, & Qi, 2015). 
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2. Methods 
2.1.  Framingham Original Cohort study dataset  
The study uses the Framingham Original Cohort study dataset (Fernandez et al., 2009). The data was 
obtained after a successful ethics approval from NHLBI and the Auckland University of Technology 
Ethics Committee (AUTEC) (Ref: 17/385 Early detection and self-management of cardiovascular 
disease using Artificial Intelligence-based Model).  
The dataset includes a cohort with a total of 5079 men and women aged 30-74 years free of CVD at 
the baseline, out of them, 3189 had CVD events eventually. Details of the CVD events distribution 
in male and female among the study population are summarized in Table 1. 
 
 
 Count CVD Events Age Range 
Male 2294 1560 30 - 74 
Female 2785 1629 30 - 74 
Total 5079 3189 30 - 74 
Table 1: CVD Event Distribution in Male and Female 
 
2.2. Data Preparation 
There are 32 exams in the Framingham Original Cohort study dataset (D’agostino et al., 2008), data 
frame collected in the first exam “Exam1” was chosen to develop the CVD prediction model because 
it has the maximum number of samples from 5209 subjects. Data from 130 subjects were removed 
because of the ethics protection. A total of 20 risk factors was used for creating the risk model, 
including age, sex, body mass index, hypertension, heart related diseases, heart beats, blood pressure, 
smoking, diabetes and other long-term conditions (Fernandez et al., 2009). 
 
2.3. Statistical Analysis 
Cox proportional hazard regression analysis was undertaken for creating the risk model (Cox, 1972). 
The prediction model included multiple parameters to estimate the probability of developing CVD 
for an individual. There are mainly three statistical approaches in survival analysis, i.e. non-
parametric, semi-parametric, and parametric approaches (Collett, 2015). The non-parametric 
approaches can only do univariate analysis with single predictor and are not suitable for the study of 
continuous variables. Both parametric and semi-parametric approaches can do multiple parameters 
analysis (Goldstein, Navar, Pencina, & Ioannidis, 2017). They all assume that the predictors and the 
log hazard rate should have a linear relationship. However, the Cox Proportional Hazard model (the 
most popular method belonging to the semi-parametric statistical method) has an advantage that only 
the rank orderings of the failure and censoring times are used to estimate and test the regression 
coefficients (Lu, Cai, Wang, Tong, & Xiang, 2018). 
Statistical analyses were performed in R Studio platform. Missing values for candidate risk factors 
were imputed using multiple imputation. Continuous and categorical variables were transformed and 
imputed using algorithms modified from Maximum Generalized Variance (MGV) in the SAS 
PRINQUAL procedure. R function ‘Function.transcan’ creates R functions to transform variables 
using transformations created by ‘transcan’ inside the “Hmisc” package was used. For candidate 
predictors we performed two steps of variables selection from the list. The first step was conducted 
in a “Forward Selection” manner, i.e. the univariate Cox analysis was applied to multiple variables 
one by one, and then insignificant predictors were filtered based on a significance level p-value 
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>0.05. In the second step, all selected variables from the univariate analysis were entered into the 
multivariate Cox regression analysis. 
In the validation stage, two approaches were undertaken to assess the predictive ability of our fitted 
model, statistical validation and empirical validation. The statistical validation was performed with 
respect to both discrimination and calibration. The empirical validation was defined as an empirical 
comparison with a general CVD risk prediction model (the Framingham office-based risk equation) 
in a horizontal and longitudinal perspective. The horizontal comparison was conducted by 
comparing with the Framingham prognostic model using data collected from multiple samples at the 
same time-point. The longitudinal comparison was conducted by comparing with the Framingham 
prognostic model using data collected from specific examples at different time-points (fixed time 
intervals follow-up) and see the risk trend for an individual over time. 
 
3. Development of the Risk Model 
3.1. Derivation of a 10-year Risk Score for CVD 
Risk factors included in the risk model are age, sex, body mass index (BMI), hypertension, 
systolic blood pressure (SBP), cigarettes per day, pulse rate, the status of diabetes. 
Characteristics of risk factors were listed in Table 2. Statistics of “Min.”, “1st Qu.” (1st quarter), 
“Median”, “Mean”, “3rd Qu.” (3RD Quarter), and “Max.” of these risk factors are summarized. 
 
Predictors Variables Min. 1st Qu. Median Mean 3rd Qu. Max. 
AGE age 28 37 44 44.15 51 74 
SEX sex 1 1 2 1.548 2 2 
BMI bmi 14.12 22.66 25.17 25.61 27.92 56.68 
HYPERTENSI
ON 
hyp 
0 0 0 0.147 0 1 
BLOOD 
PRESSURE 
SYSTOLIC 
bps 
84 122 136 138.6 150 270 
CIGARETTES 
PER DAY 
cgrpd 
0 5 20 16.26 20 60 
PULSE RATE pr 37 67 75 75.61 83 170 
DIABETES dia 0 0 0 0.0197 0 1 
Table 2:  Summary Statistics for Risk Factors Used in Risk Model 
 
The regression coefficients, hazard ratios, and their corresponding upper and lower 95% confidence 
intervals (CI) were estimated, as presented in Table 3. Values of the baseline hazard rate where the 
time point is ten years were estimated as well, shown in Table 4. The 10-year baseline hazard rate is 
0.1023354 at mean values of all covariates, 0.001863652 at all covariates equal to zero. The survival 
probability (exp(basehaz)) is 0.9027267 at mean values and 0.9981381 at all covariates equal to 
zero. 
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Predictors Variables coef* Hazard Ratio lower .95 upper .95 
AGE log of age 2.083643 8.033686 6.4082 10.0716 
SEX sex -0.469719 0.625178 0.5787 0.6754 
BMI log of bmi 0.608864 1.838342 1.4368 2.3521 
HYPERTENSION hyp 0.241461 1.273108 1.1342 1.429 
BLOOD 
PRESSURE 
SYSTOLIC 
log of bps 1.682571 5.37937 
3.7938 7.6277 
CIGARETTES 
PER DAY 
cgrpd 0.009669 1.009716 
1.0065 1.013 
PULSE RATE log of pr -0.30209 0.739271 0.5879 0.9297 
DIABETES dia 1.087501 2.96685 2.3244 3.7869 
*Estimated regression coefficient 
Table 3: Regression Coefficients and Hazard Ratios in Risk Model 
 
 Covariates at mean value Covariates equal to zero 
Baseline hazard estimate 0.1023354 0.001863652 
Baseline survival estimate 0.9027267 0.9981381 
Table 4: Baseline Hazard and Survival at 10 Years 
 
As the Cox model (Cox, 1972) defines by Equation 1, where t represents the time that the event 
occurs; 𝜆(𝑡)  is the hazard function for a subject at time t, determined by a set of m covariates (𝑋1, 
𝑋2, ..., 𝑋𝑘); 𝛽1, 𝛽2, ... 𝛽𝑘 are the regression coefficients that measure the effect size of covariates; 
exp is the exponential function (exp(X)= ex); 𝜆 0(𝑡)  is the baseline hazard rate, an arbitrary 
(unknown) function, corresponds to the value of the hazard when all 𝑋𝑖 equal to zero (Lin & Wei, 
1989). 
 
𝜆(𝑡)  =  𝜆0(𝑡)𝑒𝑥𝑝(𝛽1𝑋1 + 𝛽2𝑋2 + . . . + 𝛽k𝑋k)                    (1) 
 
So, the Cox model can be written as a survival function: 
 
(2) 
 
A general formula for computing risk estimates has the form: 
(3) 
Where, H(t) is the CVD risk estimated for an individual; S0(t) is baseline survival rate at follow-up 
time t, where t = 10 years, see Table 4, βi is the regression coefficient, see Table 3, 𝑋𝑖 is the value 
of the 𝑖𝑡ℎ risk factor (if is continuous it is the log-transformed value), ?̅?𝑖is the corresponding mean, 
and k denotes the number of risk factors. The CVD risk function could be derived from Equation 3, 
using regression coefficients from Table 2 and the baseline hazard rates from Table 3, hence, we 
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computed the probability of developing any type of CVD for an individual. 
3.2. Nomograms 
A nomogram is a two-dimensional diagram to represent a mathematical function involving several 
predictors. It is a simple graphical illustration to approximately predict a particular event based on 
conventional statistical regression methods such as Cox proportional hazards model for survival 
analysis (Cox, 1972; Lin & Wei, 1989). A nomogram is accomplishing the estimation of individual 
survivals in 10 years and the median survival time by years was depicted in Figure 1. 
In Figure 1, each predictor has a set of n scales, and there is a mapping between each scale and the 
“Points” scale. The bottoms are the corresponding 10-year survival estimates, and the median 
survival time (years).  By accumulating the total points corresponding to the specific configuration 
of covariates for a patient, a clinician can then manually obtain the predicted value of the event for 
that patient. 
 
 
 
 
Figure 1: Nomogram for Predicting Overall Survival in 10-year 
 
4. Results and Validation 
First, the validation of our predictive risk model was performed using traditional statistics. The 
C-index (also called receiver operating characteristic (ROC) area) was used to assess the 
goodness of the risk model based on a bootstrap internal resampling validation (Collins, 
Ogundimu, & Altman, 2016). From the statistical validation analysis, a C-index (area under the 
receiver operator curve [AUROC]) of 0.71 was achieved indicating the moderately good ability 
of discrimination. Secondly, we performed an empirical validation by comparing our risk 
assessment model with the Framingham Heart Study model in an external dataset horizontally 
and longitudinally over time. In the horizontal validation process, there were 2786 samples in 
the external dataset (Fernandez et al., 2009), and 1693 samples with a CVD event. Risk scores 
using The Framingham Heart Study (FHS) model (D’agostino et al., 2008) and the proposed 
risk model were computed separately. Statistics of min (lower whisker), 1st quartile (the lower 
hinge), median, 3rd quartile (the upper hinge), and max (the extreme of the upper whisker) of 
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estimated risks for all samples are depicted in Figure 2.  
The box-whisker graph in Figure 2 shows that the risks assessed by our Cox model are higher than 
the risk calculated by the Framingham model, but the error for five statistics (min, 1st Qu, median, 
mean, 3rd Qu., max) is within 0.02. For example, the median values of the FHS model and the Cox 
model are 0.1429475 and 0.1661985 respectively. For individuals with a CVD event, the Cox model 
is much more accurate than the FHS model whereas, for individuals without CVD, the Cox risk 
model overestimates the risk. Overall, the risk scale of the Cox model is consistent and is par with 
the Framingham model (D’agostino et al., 2008). 
 
 
Figure 2: Horizontal Comparison between Cox Model and FHS Model 
 
In the longitudinal validation process, we selected four sex-specific subjects with or without 
CVD from the end of the Framingham Study. A summary of these four subjects is listed in 
Table 5 to confirm the longitudinal validation of the predicted CVD event. 
 
 
Samples Gender CVD Diabetes 
Sample 1 Male ✘ ✘ 
Sample 2 Male ✓ ✓ 
Sample 3 Female ✘ ✘ 
Sample 4 Female ✓ ✓ 
Table 5: Data Summary for Samples in the Longitudinal Validation 
 
For each sample, data with fixed time intervals (approximately two years) from longitudinal 
time follow-up are extracted. The risk of developing CVD in 10 years related to the selected 
five exams data are separately computed using the Cox model and the Framingham model. 
Figure 3 shows the trend of risk over the years with 5% error and the trend of risks of these two 
models are consistent and risks for a specific sample increase over-time, the dotted trend lines 
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in each graph represents the increase in the CVD risk over-time. Also, samples (both male and 
female) with diabetes that developed CVD will have a higher risk than the ones with no 
developed CVD. 
 
Figure 3: Longitudinal Validation 
 
5. Discussion 
It is widely accepted that CVD has become one of the significant public health problems 
globally and in New Zealand and continues producing immense burdens on the healthcare 
system (Desai, Bartz, Gottdiener, Lloyd-Jones, & Gardin, 2016; Fernández-Ruiz, 2017; Wells 
et al., 2018). Previous studies have noted the importance of identifying associated risk factors 
and the early detection and intervention of CVDs and also investigated regarding reducing the 
risk of developing CVD in early stages. Consequently, CVD risk prediction tools based on a 
single variable or multiple variables have been devised to yield estimates of the CVD risk 
(McClelland et al., 2015). 
Motivated by the objective of early detection and risk estimation of CVD, the present study was 
designed to identify novel CVD risk factors, determine the effect of these factors, and then 
develop a risk prediction model based on the identified factors (Weng, Reps, Kai, Garibaldi, & 
Qureshi, 2017). Although risk factors could vary from one specific CVD component to another, 
there is sufficient evidence that different types of CVD have commonalities of risk factors. 
Concerning the aim of this research, we derived and validated a new 10-year risk equation for 
general CVDs based on time follow-up data rigorously measured by the Framingham Heart 
Study (D’agostino et al., 2008). 
This investigation extends the number of risk factors by the previous general CVD risk 
formulations, incorporating heart rate to estimate absolute CVD risk. The approach used in this 
research is based on advanced statistical techniques that allow reducing the bias in the 
assessment of true CVD risk. The whole process of data analysis strictly follows the guideline 
of regression modelling strategies and survival analysis. 
We use continuous variables (age, BMI, SBP, pulse rate) to generate the model that performs 
better than other similar models developed using categorical variables. Compared with simpler 
approaches that try to make inferences of 5-year and 10-year risk models such as the model 
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based on logistic regression analysis and the CVD risk model using Kaplan-Meier and log-rank 
test, the proposed Cox risk model is more adequate and will avoid severe errors of 
underestimation or overestimation (Arts et al., 2016). Moreover, this model was developed 
based on a more substantial number of samples and events, suggesting a valid estimation of the 
real risk (Bansilal et al., 2015; Collett, 2015; Fernandez et al., 2009; McClelland et al., 2015). 
 
6. Conclusion 
The old version of the Framingham general CVD risk function is useful for identifying 
individuals at high risk of CVD, but it was based on a limited number of risk factors (serum 
cholesterol, SBP, smoking history, electrocardiogram, and glucose intolerance) (Garg et al., 
2017). The new Framingham laboratory-test-based formula included HDL cholesterol in the 
risk function. The QRISK study investigators incorporated family history as a novel risk factor 
by the Framingham’s general guidelines. Although researchers have published risk scores for 
predicting general CVDs, these functions did not include heart rate in the risk model (Stevens, 
Stevens, Hobbs, & Lasserson, 2015). 
Risk models formulated by using machine learning or data mining techniques have incorporated 
heart rate as a risk factor but tools that can predict CVD absolute risk are fewer. For example, 
a prediction tool focuses on the classification of CVD event by employing the ANN and the 
Bayesian classifier based on heart rate variability. The diagnosis CVD model categorizes the 
CVD risk as different levels, but an absolute risk score cannot be obtained. Even though a 
supportive tool will generate the estimate of a risk score, but the user can not know how many 
years the score is targeting. 
Some equations only focused on specific CVD outcomes. The Europe SCORE project equations 
were developed for the fatal cardiovascular event (Bitik et al., 2016). These risk estimation tools 
are just for coronary heart disease. Also, there are some risk models aiming stroke. Compared 
with these disease-specific models to estimate the risk of developing specific CVD outcomes, 
the present study generated a general CVD risk tool that could predict a global CVD risk as well 
as the risk of developing individual components. 
Moreover, compared with the laboratory-based algorithms, the present research proposed a 
more straightforward way to estimate 10-year CVD risk based on risk factors without requiring 
clinical or laboratory tests such as the HDL measurement or blood test. In today’s connected 
word, an individual’s CVD risk could be assessed my many simple ways, such as using 
wearable sensors (Bitik et al., 2016; Wu, Zhang, Pirbhulal, Mukhopadhyay, & Zhang, 2015) or 
internet of things (IoT) devices (Kaappa et al., 2017; Raja, Saravanan, Anitha, Priya, & 
Subhashini, 2017; Pascoli, & Iannaccone, 2016) or self-monitoring applications (Baig, 
GholamHosseini, & Connolly, 2016; Baig, GholamHosseini, Moqeem, Mirza, & Lindén, 2017; 
Baig, Hosseini, & Lindén, 2016; GholamHosseini, Menthes, Baig, & Linden, 2016). 
The proposed study devised a risk prediction model based on office-based multivariable 
predictors. A novel risk factor ‘heart rate’ was incorporated into this risk equation by 
conventional risk factors. A satisfying predictive ability with C-index (AUROC) being 0.71 was 
obtained, which ensures the accuracy of estimating risk scores. Compared with studies focusing 
on specific diseases, this algorithm can be applied to both general CVDs and specific CVD 
components such as the stroke, heart failure, and diabetes. Moreover, this risk model is much 
more convenient compared to models based on laboratory test predictors. Practitioners can 
perform this equation to quantify risk during a patient visit and identify high-risk individuals 
for further preventive health care. 
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